reference/17345225

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17345225

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	150
issn	0167-6806 1573-7217
issueIdentifier	1
pageRange	145-150
publicationName	Breast Cancer Research and Treatment
startingPage	145
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8c4110f9ea22947f558204099339181b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d268d64b6ba4092e2b60d3466002b390
bibliographicCitation	Johnatty SE, Beesley J, Chen X, Hopper JL, Southey MC, Giles GG, Goldgar DE, Chenevix-Trench G, Spurdle AB, The Australian Ovarian Cancer Study Group, The Kathleen Cuningham Consortium for Research in Familial Breast Cancer. The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis. Breast Cancer Research and Treatment. 2008 May 15;115(1):145–50. doi: 10.1007/s10549-008-0045-y.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1878-2587 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61790242cbe9327a0ed47ea506d7c37a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d048468ad750e0a27ab1caafab047cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8788464258042f1a3530dcd62a58edf5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1749eec0c40b211e0ab1abb4fc72eb09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d65826151f108c8a0509bf016efd41e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10645ac4582567f439622b796e103d53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6d30b99b958d904aca85ac48f7de30a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a197c0f4e2e0921cfb4aae1958c575e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92cd446d4853012845728fd951a3d43d
date	2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s10549-008-0045-y https://pubmed.ncbi.nlm.nih.gov/18481171
isPartOf	https://portal.issn.org/resource/ISSN/1573-7217 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1254 https://portal.issn.org/resource/ISSN/0167-6806
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis
discusses	http://id.nlm.nih.gov/mesh/M0019675 http://id.nlm.nih.gov/mesh/M0268250 http://id.nlm.nih.gov/mesh/M0374857 http://id.nlm.nih.gov/mesh/M0005539 http://id.nlm.nih.gov/mesh/M0446168
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_542d8579df0f71fc9e15ed03e15b95c4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_533622b82f51bc5431a771c088f3bdd9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID3159

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID580 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742316 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643942

Total number of triples: 49.